ARTICLE | Company News
Avacta, Glythera deal
July 25, 2016 7:00 AM UTC
Avacta and Glythera partnered to develop targeted therapeutics using Avacta’s Affimer technology and Glythera’s PermaLink conjugation chemistry. The partners said Affimer reagents and PermaLink chemi...